🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, single-arm, multicenter study to evaluate the activity ...
Status
Recruiting
Location
AUSL-IRCCS of Reggio Emilia
Start Date
2024-01-16
Trial ID
NCT06464068
Treatments Being Tested
This study is a multi-cohort, open-label, multi-center exploratory clinical...
Status
Not Yet Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-10-10
Trial ID
NCT06649448
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2022-07-13
Trial ID
NCT05019716
This trial aims to assess efficacy and safety of durvalumab combined with c...
Status
Recruiting
Location
Fourth Hospital of Hebei Medical University
Start Date
2023-06-01
Trial ID
NCT06371482
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested
This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expa...
Status
Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2023-09-05
Trial ID
NCT05652686
The purpose of this study is to evaluate: 1. whether an imaging test calle...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2007-07
Trial ID
NCT00530179
Treatments Being Tested
This study will evaluate the efficacy and safety of Iparomlimab and Tuvonra...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-31
Trial ID
NCT07349225
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of molibresib ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09-18
Trial ID
NCT04116359
Treatments Being Tested